A detailed history of Pro Share Advisors LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,199 shares of CDXS stock, worth $67,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,199
Holding current value
$67,578
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.62 - $3.71 $34,581 - $48,968
13,199 New
13,199 $40,000
Q1 2024

May 08, 2024

BUY
$2.59 - $4.65 $2,558 - $4,594
988 Added 8.56%
12,526 $43,000
Q4 2023

Feb 14, 2024

SELL
$1.54 - $3.37 $2,596 - $5,681
-1,686 Reduced 12.75%
11,538 $35,000
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.75 $345 - $862
230 Added 1.77%
13,224 $24,000
Q2 2023

Aug 10, 2023

BUY
$2.21 - $4.43 $2,687 - $5,386
1,216 Added 10.32%
12,994 $36,000
Q1 2023

May 11, 2023

SELL
$3.81 - $6.76 $5,894 - $10,457
-1,547 Reduced 11.61%
11,778 $48,000
Q4 2022

Feb 02, 2023

BUY
$4.26 - $6.84 $4,549 - $7,305
1,068 Added 8.71%
13,325 $62,000
Q3 2022

Nov 04, 2022

BUY
$6.06 - $12.86 $1,787 - $3,793
295 Added 2.47%
12,257 $74,000
Q2 2022

Aug 01, 2022

SELL
$8.35 - $21.89 $50,659 - $132,806
-6,067 Reduced 33.65%
11,962 $125,000
Q1 2022

May 10, 2022

SELL
$16.97 - $31.93 $72,275 - $135,989
-4,259 Reduced 19.11%
18,029 $371,000
Q4 2021

Feb 08, 2022

BUY
$25.61 - $41.78 $19,668 - $32,087
768 Added 3.57%
22,288 $697,000
Q3 2021

Nov 12, 2021

SELL
$19.65 - $27.99 $111,729 - $159,151
-5,686 Reduced 20.9%
21,520 $501,000
Q2 2021

Aug 13, 2021

BUY
$17.48 - $25.46 $52,457 - $76,405
3,001 Added 12.4%
27,206 $616,000
Q1 2021

May 14, 2021

BUY
$18.08 - $28.8 $57,548 - $91,670
3,183 Added 15.14%
24,205 $554,000
Q4 2020

Feb 09, 2021

BUY
$11.7 - $23.41 $245,957 - $492,125
21,022 New
21,022 $459,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.